Oral tolerance

Journal of Clinical Immunology

Volumn 18, Issue 1, 1998, Pages 1-30

  Strober, Warren ^a,c   Kelsall, Brian ^a   Marth, Thomas ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAARLAND UNIVERSITY   (Germany)

^c Building 10 11N238 ^*  (United States)

Author keywords

Anergy; B cell; Clonal deletion; Cytokines; IFN ; IgA; IL 12; IL 4; Immunoglobulin; Lamina propria; Macrophage; Oral tolerance; Peyer's patch; Suppression; Suppressor cell; T cell; TGF ; Tolerance

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN TYPE 2; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN; MYELIN BASIC PROTEIN; RETINA S ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL TRIAL; CLONAL ANERGY; CROHN DISEASE; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MUCOSA; MULTIPLE SCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SUPPRESSOR CELL; ULCERATIVE COLITIS; UVEITIS;

HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MOUTH MUCOSA;

EID: 0031912369     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023222003039     Document Type: Review

References (135)

1. Asherson GL, Zembala M, Perera MACC, Mayhew B, Thomas WR: Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents, and the role of suppressor cells in the Peye's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol 33:145-155, 1977
2. Tomasi TB: Oral tolerance. Transplantation 29:353-356, 1980
3. Kagnoff MF: Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed type hypersensitivity reactions. J Immunol 120:1509-1513, 1978
4. MacDonald TT: Immunosuppression caused by antigen feeding. II. Suppressor T cells musk Peyer's patches B cell priming to orally administered antigen. Eur J Immunol 13:138-142, 1983
5. Stokes CR, Newby TJ, Huntley JH, Patel D, Bourne FJ: The immune response of mice to bacterial antigens given by mouth. Immunology 38:497-502, 1979
6. Titus RG, Chiller JM: Orally induced tolerance: Definition at the cellular level. Int Arch Allergy Appl Immunol 65:323-338, 1981
7. Reese RT, Cebra JJ: Anti-dinitrophenyl antibody production in strain 13 guinea pigs fed or sensitized with dinitrochlorobenzene. J Immunol 114:863-871, 1975
8. Aizpura H, Russell-Jones G: Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med 167:440-451, 1988
9. Elson CO, Ealding W: Generaliszed systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736-2741, 1984
10. Mowat AM, Thomas JJ, Parrott DMV: Divergent effects of bacterial lipopolysaccharide on immunity to orally administered protein and particular antigens in mice. Immunology 58:677-684, 1986
11. Strobel S, Ferguson A: Persistence of oral tolerance in mice fed ovalbumin is different for humoral and cell-mediated immune responses. Immunology 60:317-318, 1987
12. Zhang X, Brunner T, Carter L, Dutton, R, Rogers P, Bradley L, Sato T, Reed J, Green D, Swain S: Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185:1837-1849, 1997
13. Ngan J, Kind LS: Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin. J Immunol 120:861-865, 1978
14. Sacklayen MG, Pesce AJ, Pollak VE, Michael JG: Kinetics of oral tolerance: Study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immunol 73:5-9, 1984
15. Challacombe SJ, Tomasi JB: Systemic tolerance and secretory immunity after oral immunization. J Exp Med 152:1459-1472, 1980
16. Fujihashi K, McGhee J, Yamamoto M, Hiroi T, Kiyono H: Role of lambda-delta T cells in the regulation of mucosal IgA response and oral tolerance. In Oral Tolerance, H. Weiner, L. Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 55-63
17. Gesualdo L, Lamm ME, Emancipator S: Detective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J Immunol 145:3684-3691, 1990
18. Richman L, Chiller J, Brown W, Hanson D, Vaz N: Enterically induced immunologic tolerance. I. Induction of suppressor T lymphocytes by intragastric administration of soluble proteins. J Immunol 121:2429-2434, 1978
19. Elson C, Edding W: Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132:2736-2741, 1984
20. Kagnoff M, Cambell S: Functional characteristics of Peyer's patch lymphoid cells I. Induction of humoral antibody and cell-mediated allograft reactions. J Exp Med 139:398, 1974
21. Chase M, Battisto J: The duration of dermal sensitization following cellular transfer in guinea pigs. J Allergy 26:83, 1955
22. Thomas HC, Ryan CJ, Benjamin IS, Blumgart LH, MacSween RN: The immune response in cirrhotic rats. The induction of tolerance to orally administered protein antigens. Gastroenterology 71:114-117, 1976
23. Richman LK, Graeff AS, Strober W: Antigen presentation by macrophage-enriched cells from the mouse Peyer's patch. Cell Immunol 62:110-118, 1981
24. MacDonald T: Immunosuppression caused by antigen feeding. I. Evidence for the activation of a feedback suppressor pathway in the spleens of antigen-fed mice. Eur J Immunol 12:767-773, 1982
25. Nussenblatt R, Caspi R, Mahdi R, et al.: Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 144:1689-1696, 1990
26. Lider O, Santos L, Lee C, Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142:748-752, 1989
27. Vistica B, Chanaud N, Felix N, et al.: CD8 T-cells are not essential for the induction of "low-dose" oral tolerance. Clin Immunol Immunopathol of 78:196-202, 1996
28. Chen Y, Inobe J, Weiner H: Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4+ and CD8+ cells mediate active suppression. J Immunol 155:910-916, 1995
29. Tada Y, Ho A, Koh D-R, Mak T: Collagen-induced arthritis in CD4- or CD8-deficient mice. CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 156:4520-4526, 1996
30. Desvignes C, Bour H, Nicolas J, Kaiserlian D: Lack of oral tolerance but oral priming for contact sensitivity to dinitroflorobenzene in major histocompatibility complex class II-deficient mice and in CD4+ T cell-depleted mice. Eur J Immunol 26:1756-1761, 1996
31. Miller A, Lider O, Weiner H: Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791-798, 1991
32. Miller A, Al-Sabbagh A, Santos L, Prabhu-Das M, Weiner H: Epitopes of myelin basic protein (MBP) that trigger TGF-β release following oral tolerization to MBP are different from encephalitogenic epitopes. J Immunol 151:7307-7315, 1993
33. Von Herrath M, Dyrberg T, Oldstone M: Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324-1331, 1996
34. Schluesener H, Lider O: Transforming growth factors beta 1 and beta 2: Cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol 24:249-258, 1989
35. Karpus W, Swanborg R: CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor β. J Immunol 146:1163-1169, 1991
36. Higgins P, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440-445, 1988
37. Nagler Anderson C, Bober L, Robinson M, Siskind G, Thorbecke G: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II antigen. Proc. Natl Acad Sci USA 83:7443, 1986
38. Khoury SJ, Hancock WW, Weiner HL: Oral tolerence to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, prostaglandin E expression in the brain. J Exp Med 176:1355-1364, 1992
39. Miller A, Lider O, Roberts A, Sporn M, Weiner H: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor after antigen-specific triggering. Proc Natl Acad Sci USA 89:421-425, 1992
40. Powrie F, Correa-Oliveira R, Mauze S, Coffman R: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589-600, 1994
41. Powrie F, Carlino J, Leach M, Mauze S, Coffman R: A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type l-mediated colitis by CD45RBlow CD4+ T cells. J Exp Med 183:2669-2674, 1996
42. Neurath M, Fuss I, Kelsall B, Stuber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290, 1995
43. Neurath M, Fuss I, Kelsall B, Presky D, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 183: 2605-2616, 1996
44. Miller A, Zhang Z, Sobel R, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. J Neuroimmunol 46:73-82, 1993
45. Kearney E, Pape K, Loh D, Jenkins M: Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327-339, 1994
46. Perez V, Van Parijs L, Biuckians A, Zheng X, Strom T, Abbas A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411-417, 1997
47. Kulkarni A, Huh C, Becker D. et al.: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774, 1993
48. Marth T, Stroher W, Kelsall B: High dose oral tolerance in ovalbumin TCR transgenic mice: Systemic neutralization of interleukin-12 augments TGFβ secretion and T cell apoptosis. J Immunol 157:2348-2357, 1996
49. Marth T, Strober W, Seder R, Kelsall B: Regulation of transforming growth factor-β production by interleukin-12. Eur J Immunol 27:1213-1220, 1997
50. Seder R, Marth T, Sieve M, Stroher W, Kelsall B: Factors involved in the differentiation of TGF-β-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own products.
51. Seder R, Paul WE: Acquisition of lymphokine-producing pheno-type by CD4+ T cells. Annu Rev Immunol 12:635-673, 1994
52. Friedman A, Weiner H: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688-6692, 1994
53. Chen Y, Inobe J, Kuchroo V, Baron J, Chaneway C, Weiner H: Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 93:388-391, 1996
54. Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalitis. Science 265:1237-1240, 1994
55. Chen Y, Weiner H: Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann NY Acad Sci 778:111-121, 1996
56. Inobe JI, Chen Y, Weiner HL: In vivo administration of IL-4 induces TGFβ producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778: 390-392, 1996
57. Weiner H: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335-343, 1997
58. Fukaura H, Kent S, Pietrusewic M, Khoury S, Weiner H, Hafler D: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β-1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70-77, 1996
59. Caspi R, Stiff L, Morawetz N, et al.: Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann NY Acad Sci 778:315-337, 1996
60. Garside P, Steel E, Worthey A, et al.: Th2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 154:3549-3555, 1995
61. Chen Y, Inohe J, Marks R, Gonella P, Kuchroo V, Weiner HL: Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177-180, 1995
62. Ehrhardt R, Ludviksson B, Gray B, Neurath M, Strober W: Induction and prevention of colonie inflammation in IL-2-deficient mice. J Immunol 158:566-573, 1997
63. Ludviksson B, Gray B, Strober W, Ehrhardt R: Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J Immunol 158:104-111, 1997
64. Marinaro M, Staats H, Hiroi T, Jackson R, Coste M, Boyaka P, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee J: Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 155:4621-4629, 1995
65. Ke Y, Pearce K, Lake J, Ziegler H, Kapp J: Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 158:3610-3618, 1997
66. Ke J, Kapp J: Oral Antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol 156:916-921, 1996
67. Mengel J, Cardillo F, Aroeira L, Williams O, Russo M, Vaz N: Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol Lett 48:97-102, 1995
68. Wildner G, Hunig T, Thurau S: Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis. Eur J Immunol 26:2140-2148, 1996
69. Harrison L, Dempsey-Collier M. Kramer D, Takahashi K: Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 184:2167-2174, 1996
70. McMenamin C, Pimm C, McKersey M, Holt P: Regulation of IgK responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 265:1869-1871, 1994
71. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt P: Gamma delta T cells down-regulate primary IgK responses in rats to inhaled soluble protein antigens. J Immunol 154:4390-4394, 1995
72. Blumberg R, Balk S: Intraepithelial lymphocytes and their recognition of non-classical MHC molecules. Int Rev Immunol 11:15-30, 1994
73. Blumberg R, Terhorst C, Bleicher P, et al.: Expression of a nonpolymorphic MHC class I-like molecule CD1d, by human intestinal epithelial cells. J Immunol 147:2518-2524, 1991
74. Bruce MG, Ferguson A: Oral tolerance to ovalbumin in mice: Studies of chemically modified and of "biologically filtered" antigen. Immunology 57:627-630, 1986
75. Bruce M, Ferguson A: The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 159, 1986
76. Strobel S, Mowat A, Drummond H, Pickering M, Ferguson A: Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide sensitive cells by gut processed antigen. Immunology 49:451-456, 1983
77. Peng H, Turner M, Ferguson A: The generation of a tolerogen after the ingestion of ovalbumin is time dependent and unrelated to the serum level of immunoreactive protein. Clin Exp Immunol 81:510-515, 1990
78. Lamont A, Bruce M, Watret K, Ferguson A: Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization. Immunology 64:135-140, 1988
79. Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology 66:416-421, 1989
80. Kay R, Ferguson A: The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology 66:410-415, 1989
81. Whitacre C, Gienapp I, Orosz C, Bitar D: Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 147:2155-2163, 1991
82. Gregerson D, Obritsch W, Donoso L: Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low dose versus high dose feeding protocols. J Immunol 151:5751-5761, 1993
83. Van Houten N, Blake S: Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 157:1337-1341, 1996
84. Schwartz R: Immunological tolerance. In Fundamental Immunology, WE Paul (ed). New York: Raven Press, 1993, pp 677-731
85. Lamont AG, Mowat A, Mcl., Browning MJ, Parott DMV: Genetic control of oral tolerance to ovalbumin in mice. Immunology 63:737-739, 1988
86. Mowat A, Lamont A, Bruce M: A genetically determined lack of oral tolerance to ovalbumin is due to failure of the immune system to respond to intestinally derived tolerogen. Eur J Immunol 17:1673-1676, 1987
87. Mowat A: The regulation of immune responses to dietary protein antigens. Immunol Today 8:93-98, 1987
88. Brown D, Moskowitz N, Killeen N, Reiner S: A role for CD4 in peripheral T cell differentiation. J Exp Med 186:101-107, 1997
89. Kagnoff M: Immunology and inflammation of the gastrointestinal tract. In Gastrointestinal Diseases, MH Sleisenger, JS Fordtran (eds). 1993, pp 45-86
90. Troncone R, Ferguson A: In mice, gluten in maternal diet primes systemic immune responses to gliaden in offspring. Immunology 64:533-537, 1988
91. Kiyono H, McGhee J, Wannemuehler M, Michalek S: Lack of oral tolerance in C3H/HeJ mice. J Exp Med 155:605-610, 1982
92. Michalek S, Kiyono H, Wannemuehler M, Mosteller L, McGhee JR: Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction. J Immunol 128:1992-1998, 1982
93. Khoury S, Lider O, Al-Sabbagh A, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol 131:302-310, 1990
94. Strobel S, Ferguson A: Modulation of intestinal and systemic immune responses to a fed protein antigen, in mice. Gut 27:829-837, 1986
95. Mowat AM, Parrott DMV: Immunological responses to fed protein antigens in mice. IV. Effects of stimulating the reticuloendothelial system on oral tolerance and intestinal immunity to ovalbumin. Immunology 50:547-554, 1983
96. Zhang Z, Michael JG: Orally inducible immune responsiveness is abrogated by IFN-γ treatment. J Immunol 144:4163-4165, 1990
97. Kweon H, Fujihashi K, Yamamoto M, VanCott JL, McGhee JR, Kiyono H: Mucosally induced tolerance in IL-4-/- but not IFN gamma-/- mice. FASEB J 10:A1028, 1996
98. Kjerrulf M, Grdic D, Lycke N: Impaired mucosal IgA responses by intact oral tolerance in IFN-lambda receptor deficient mice. FASEB J 10:A1418, 1996
99. Weiner H: Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48: 341-351, 1997
100. Ludviksson BR, Ehrhardt RO, Strober W: TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol 159:3622-3628, 1997
101. Hornquist E, Lycke N: Cholera toxin increases T lymphocyte responses to unrelated antigens. Adv Exp Med Biol 1995:1507-1512, 1995
102. Marinaro M, Boyaka P, Finkelman F, Kiyono H, Jackson R, Jirillo E, McGhee J: Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185:415-427, 1997
103. Takahashi I, Marinaro M, Kiyono H, et al.: Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173:627-635, 1996
104. Sun J, Rask C, Olsson T, Holmgren J, Czerkinsky C: Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA 93:7196-7201, 1996
105. Mowat A: Depletion of suppressor T cells by 2′-deoxyguanosine abrogates tolerance in mice fed ovalbumin and permits the induction of intestinal delayed-type hypersensitivity. Immunology 58:179-184, 1986
106. Nelson P, Akselband Y, Dearborn S, et al.: Effect of oral beta interon on subsequent immune responsiveness. In Oral Tolerance: Mechanisms and Applications, HL Weiner, LF Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 145-155
107. Elson C, Tomasi M, Dertzbaugh M, Thaggard G, Hunter R, Weaver C: Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. In Oral Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, Vol 778, pp 156-162
108. Karpus W, Lukacs N: The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1. In Oral Tolerance: Mechanisms and Applications, H Weiner, L Mayer (eds). New York: The New York Academy of Sciences, 1996, pp 133-144
109. Strober W, Neurath MF: Immunological diseases of the gastrointestinal tract. In Clinical Immunology, RR Rich (eds). St. Louis: Mosby, 1995, pp 1401-1428
110. Sollid LM, Markussen G, Ek J: Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169:345, 1989
111. Ferguson A (ed): In Models of Immunologically-Driven Small Intestinal Damage, MN Marsh (ed), Chichester: John Wiley and Sons, 1987, pp 225-252
112. Nilsen EM, Lundin Ke, Krajci P, Scott H, Sollid LM, Brandtzaeg P: Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766-776, 1995
113. Strokes CR, Miller BG, Bourne FJ: Animal models of food sensitivity. In Food Alergy and Intolerance, J Brostoff, SJ Challacombe (eds). Eastbourne: Saunders, 1987, pp 286-300
114. Barratt MEJ, Powell JR, Allen WD, Porter P (eds): Immunopathology of intestinal disorders in farm animals. In Immunopathology of Intestinal Disorders in Farm Animals, MN Marsh (ed). Chichester: John Wiley and Sons, 1987, pp 253-258
115. Podolsky DK: Inflammatory bowel disease. N Engl J Med 325:928-937, 1991
116. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiochhi C, Strober W: Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 157:1261-1270, 1996
117. Van Dulleman HM, Van Deventer SJ, Hommes DW, Biji HA, Jansen J, Tytgat GN: Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (CA2). Gastroenterology 109:129-135, 1995
118. Strober W, Ehrhardt RO. Cronic Intestinal inflammation: An unexpected outcome of cytokine or T cell receptor mutant mice. Cell 75:203-205, 1993
119. Takahashi I, Kiyono H, Hamada S: CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112:1876-1886, 1997
120. Neurath MF, Pettersson S, Meyer zum Buschenfelde K-H, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kB abrogates established experimental colitis in mice. Nature Med 2:998-1003, 1996
121. Neurath M, Fuss I, Pasparakis M, Alexopoulos L, Haralambous S, Meyer zum Buschenfeld K-H, Strober W, Kollias G: Predominant pathogenic role of tumor necrosis factor alpha in experimental colitis in mice. Eur J Immunol 27:27-34, 1997
122. Sartor BD, Roth HC, Sellon RK: Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 12:327-333, 1996
123. Meyer AL, Benson JM, Gienapp IE, Cox K, Whitacre CC: Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis hy the oral administration of myelin basic protein. J Immunol 157:4230-4238, 1996
124. Brod S, Al-Sabbagh R, Hafler D, Weiner H: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Supression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol 29:615-622, 1991
125. Zhang ZJA, Davidson L, Eisenharth G, Weiner HL: Suppression of diahetes in NOD mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
126. Tian J, Atkinson MA, Clare-Salzler M, Forsthuber T, Lehmann PV, Kaufman DL: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183:1561-1567, 1996
127. Thompson HSG Staines NA: Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64:581-586, 1986
128. Peterson KE, Braley-Mullen H: Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell Immunol 166:123-130, 1995
129. Sayegh MH, Zhang ZJA, Hancock WW, Kwok CA, Carpenter CB. Weiner HL: Down-regulation of the immune response to histocompatibility antigen and prevention of sensitization by skin allografts by orally administered autoantigen. Transplantation 53:163-166, 1992
130. Wang ZY, Huang, J. Olsson T, He B. Link H: B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J Neurol Sci 128:167-174, 1995
131. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO: Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663-4670, 1994
132. Weiner HL: Treatment of autoimmune diseases by oral tolerance to autoantigens. Autoimmunity 15(Suppl):6-7, 1993
133. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral type II collagen treatment in early rheumatoid arthritis. Arthr Rheum 39:41-51, 1996
134. Nussenblatt R, Whiteup S, de Smet M, Caspi R, Kozhich A, Weiner H, Vistica B, Gery I: Intraocular inflammatory disease (uveitis) and the use of oral tolerance: A status report. Ann NY Acad Sci 778:325-327, 1996
135. Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Hafler DA, Foster CS, Whiteup SM. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 123:583-592, 1997